Aptevo Therapeutics Stock Quote APVO - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.156

Bid

0.1559

Ask

0.156

Volume

548,369

0.153 Day's Range 0.1672

0.141 52 Week Range 21.56

Market Cap

1.47M

Previous Close

0.1647

Open

0.161

Last Trade

100

0.156

Last Trade Time

13:50:10

Financial Volume

$ 88,389

VWAP

0.161185

Average Volume (3m)

6,875,743

Shares Outstanding

9,420,489

Dividend Yield

PE Ratio

-0.09

Earnings Per Share (EPS)

-1.85

Revenue

Net Profit

-17.41M

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aptevotherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

Aptevo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APVO. The last closing price for Aptevo Therapeutics was $0.16. Over the last year, Aptevo Therapeutics shares have traded in a share price range of $ 0.141 to $ 21.56.

Aptevo Therapeutics currently has 9,420,489 shares outstanding. The market capitalization of Aptevo Therapeutics is $1.55 million. Aptevo Therapeutics has a price to earnings ratio (PE ratio) of -0.09.

FeaturedCBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0218	-12.2609673791	0.1778	0.1797	0.153	549565	0.16564058	CS
4	-0.199	-56.0563380282	0.355	0.3833	0.141	2588337	0.26417269	CS
12	-0.1435	-47.9131886477	0.2995	0.6559	0.141	6875743	0.52722158	CS
26	-3.364	-95.5681818182	3.52	4.87	0.141	3734119	0.58400818	CS
52	-14.364	-98.9256198347	14.52	21.56	0.141	2130743	1.64473268	CS
156	-647.084	-99.9758976577	647.24	971.5156	0.141	1132366	193.92659678	CS
260	-25.364	-99.3887147335	25.52	2640	0.141	872186	271.80873209	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LASELaser Photonics Corporation	$ 7.8999 (82.87%)	41.63M
OTRKOntrak Inc	$ 2.89 (58.79%)	83.69M
PDYNPalladyne AI Corporation	$ 2.75 (46.28%)	16.08M
PRTGPortage Biotech Inc	$ 7.19 (31.44%)	326.99k
WWWW International Inc	$ 1.02 (29.21%)	22.33M
VINCVincerx Inc	$ 0.4762 (-31.78%)	7.39M
SOBRSOBR Safe Inc	$ 7.08 (-29.90%)	867.58k
DBGIDigital Brands Group Inc	$ 0.205 (-27.56%)	2.98M
KXINKaixin Holdings	$ 0.1951 (-26.79%)	17.94M
ZJKZJK Industrial Company Ltd	$ 4.98 (-26.76%)	336.83k
AGRIAgriFORCE Growing Systems Ltd	$ 0.055658 (15.95%)	310.32M
NVDANVIDIA Corporation	$ 132.1001 (3.43%)	193.06M
XPONExpion360 Inc	$ 0.0314 (-8.19%)	184.97M
VERBVerb Technology Company Inc	$ 0.046579 (10.90%)	125.76M
ALCEAlternus Clean Energy Inc	$ 0.1689 (12.68%)	121.44M